Metcela's Series A Round

Metcela raised a round of funding on August 30, 2018.

Metcela (メトセラ) is developing and commercializing an effective and reasonably-priced therapy for heart failure & cardiac diseases using specific fibroblast cells called VCF, which are obtained …

Articles about Metcela's Series A Round: